Buy BCE for the dividend, Christine Poole says

Christine Poole
Canadian telecom company BCE Inc. (Quote, Chart TSX, NYSE:BCE) has been a definite bummer of a stock this year, but how can you say no to that hefty dividend yield, now up over 5.5 per cent? For risk-averse investors it’s a no brainer, says Christine Poole of GlobeInvest Capital Management, who maintains that BCE’s track record shows it’s unlikely to be trimming its dividend anytime soon.

At close on Tuesday, BCE’s share price was up 0.7 per cent to $53.24, which nonetheless represents a drop of 11.6 per cent for the year and 15.3 per cent off its most recent high, set in early December of last year. That was when Canada’s big telcos all started falling as investors, responding to the higher interest rate environment, chose to vacate utilities.

But whereas both Rogers and Telus have handily won back their losses and then some, the same can’t be said for BCE (nor for Shaw Communications, for that matter).

BCE reported its second quarter earnings last month, featuring a consensus beat on wireless subscriber growth but producing a slim 1.7 year-over-year growth in revenue, coupled with profit for the quarter of $755 million, a 7.2 per cent year-over-year drop.

“We do hold it for some of our income-oriented investors and we do like the yield,” says Poole, CEO and managing director at GlobeInvest Capital, to BNN Bloomberg. “BCE along with some of the other telecom names have pulled back — once again, interest-sensitive — and I think for BCE, they have a record of increasing their dividends fairly regularly. They’re always managing to squeeze out more costs and grow their cash flow.”

“As we know, wireless is really the main growth area for all of these telecom companies and they continue to surprise by getting everyone to pay more per user,” she says. “I think you can buy it for the dividend, it’s safe. I think you can still count on increases within that four to six per cent level every year.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: bce
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

8 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

8 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

9 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

23 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago